BETA DRUGS
Back to Balance Sheet
|
BETA DRUGS Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹158 Cr | ₹114 Cr | ₹75 Cr | ₹70 Cr | ₹60 Cr |
What is the latest Total Non-Current Assets ratio of BETA DRUGS ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2026 | ₹158 Cr |
| Mar2025 | ₹114 Cr |
| Mar2024 | ₹75 Cr |
| Mar2023 | ₹70 Cr |
| Mar2022 | ₹60 Cr |
How is Total Non-Current Assets of BETA DRUGS Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹158 Cr | 38.68 | |
| Mar2025 | ₹114 Cr | 52.39 | |
| Mar2024 | ₹75 Cr | 7.60 | |
| Mar2023 | ₹70 Cr | 15.48 | |
| Mar2022 | ₹60 Cr | - | |
Compare Total Non-Current Assets of peers of BETA DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BETA DRUGS | ₹2,017.3 Cr | -0.1% | 6.9% | 8.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,291.0 Cr | -1.8% | 7.6% | 11.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹305,014.0 Cr | 3.7% | 27.2% | 71.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,333.0 Cr | -2.3% | 1.5% | 23.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,017.0 Cr | 0.6% | 13.4% | 15.7% | Stock Analytics | |
| CIPLA | ₹112,539.0 Cr | -1.3% | 6.1% | -6.9% | Stock Analytics | |
BETA DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BETA DRUGS | -0.1% |
6.9% |
8.8% |
| SENSEX | 0.7% |
11.7% |
-2% |
You may also like the below Video Courses